Company intelligence / Profile preview

Presage Biosciences

Seattle, Washington, United Statespresagebio.com ↗
Ownership
Private
Development stage
Other
01

Overview

Presage Biosciences developed the CIVO® platform to enable simultaneous evaluation of multiple oncology drugs or combinations directly within patient tumors. The company has completed first-in-human Phase 0 studies demonstrating proof-of-concept for this approach, including recent work with a ROR1-targeting antibody from Pure Biologics. The technology provides detailed molecular profiling and immune response data from real human tumor microenvironments, aiming to accelerate translational oncology research and improve predictive power over traditional preclinical models.

Therapeutic areas
Oncology
Modalities
Small moleculesMonoclonal antibodiesDrug combinationsImmuno-oncology agents
Industry
Biotech
02

Partnerships

Celgene Corporation (strategic collaboration)Millennium Pharmaceuticals/Takeda Oncology CompanyPure Biologics (recent co-development using CIVO)various pharma partners for drug testing collaborations.

Beyond the preview

Go deeper on Presage Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Presage Biosciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call